Pierre Le Ber
CEO
MB
Minos Biosciences
Minos Biosciences combines multi-omics analysis with dynamic functional assays at single-cell resolution using its CAGE-tag™ microfluidic technology to provide a detailed understanding of cellular diversity and dynamics. This approach generates unique datasets that enhance insights into complex biological systems, such as tumors, facilitating advancements in precision medicine and diagnostics.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
- Hardware
Updated 7 months ago
Funding
Raised to date
$4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Current single-cell technologies provide a fragmented view of cellular diversity, lacking the ability to connect multi-omics analysis with dynamic functional assays at cell resolution. Existing methods often fail to capture the full picture of molecular mechanisms underlying cell function and dynamics in complex biological systems like tumors. The constraints of droplet microfluidics limit the ability to identify cells by imaging, preventing the coupling of phenotypic and omic analysis.
Solution
Minos Biosciences offers a cell analysis platform that bridges molecular and cell biology by connecting multi-omics analysis with dynamic functional assays at single-cell resolution. Their CAGE-tag™ microfluidic technology combines image-based, dynamic functional monitoring and sequence-based molecular profiling of individual or multiple cells at high throughput. This generates unique datasets that provide an in-depth understanding of cellular diversity and dynamics in complex biological systems, such as tumors and their micro-environment. The platform includes a benchtop instrument and an integrated or cloud-based AI-powered software for streamlined and user-friendly data analysis.
Target Audience
The primary audience includes researchers in life sciences, drug discovery & development, and precision medicine, particularly those studying cancer, autoimmune disorders, and infectious diseases.
Features
- CAGE-tag™ microfluidic technology for combined image-based functional monitoring and sequence-based molecular profiling
- High-throughput analysis of individual or multiple cells
- Multi-omics analysis at single-cell resolution
- Benchtop instrument for running assays
- Integrated or cloud-based AI-powered software for streamlined data analysis
- Thermoactuatable hydrogel micro-cages for compartmentalizing single cells
- Unique barcode specific for each micro-cage